LP3 Network Free Webinar - Veterinary Compounding, A Customized Approach

Download in electronic PDF format for $25



Search the Complete Journal Archives

Pharmacokinetics of Sumatriptan 25-mg Oral Tablet Versus 25-mg Extemporaneous Suppository in Healthy Volunteers

Author(s):  Desai Hiral D, Shirley Kara L, Penzak Scott R, Strom J Grady, Hon Yeun Yi, Spratlin Vicky, Jann Michael W

Issue:  Nov/Dec 2003 - Compounding for Investigational Studies
View All Articles in Issue

Abstract:  The pharmacokinetics of an extemporaneous 25-mg suppository formulation of sumatriptan were compared to those of the marketed 25-mg oral tablet. Sixteen healthy volunteers enrolled in this open-label, two-way crossover study. Fifteen subjects completed the study. The pharmacokinetics of the suppository and the oral tablet were significantly different. Tmax was observed at 0.5 hours in 12 of 15 subjects with the extemporaneous suppository, compared with the range of 0.75 hours to 1.5 hours in 13 of 15 subjects with the oral tablet. The mean Cmax and area under the plasma concentration time curve were 5.4-fold and fourfold greater for the suppository than for the oral tablet. Both formulations were well tolerated, with mild headache experienced in only three subjects. Based upon its pharmacokinetic profile, the extemporaneous suppository may represent a useful alternative therapeutic administration route for some patients.

Related Keywords: Desai, PharmD, Hiral D., Hon, PharmD, Yuen Yi, Jann, PharmD, Michael W., Penzak, PharmD, Scott R., Shirley, PharmD, Kara L., Spratlin, MD, Vicky, Strom, PhD, J. Grady, Sumatriptan, pharmacokinetics of

Related Categories: PAIN MANAGEMENT, PEER-REVIEWED

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Pharmacokinetics of Sumatriptan 25-mg Oral Tablet Versus 25-mg Extemporaneous Suppository in Healthy Volunteers Desai Hiral D, Shirley Kara L, Penzak Scott R, Strom J Grady, Hon Yeun Yi, Spratlin Vicky, Jann Michael W Nov/Dec 2003 481-484 Buy
Compounding for Diabetic Patients:An Interview with Paul Lofholm, PharmD Allen Loyd V Jr Nov/Dec 1997 381-385 Buy
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal) Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand Mar/Apr 2016 148-154 Buy
Extemporaneous Compounding of Medicated Ointment Nagel Karen, Ali Fatima, Al-Khudari Sarah, Khan Ayesha, Patel Khushbu, Patel Nikunj, Desai Archana Nov/Dec 2010 472-478 Buy
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles Dewulf Joseph, Hecq Jean-Daniel, Huvelle Sophie, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M May/Jun 2015 268-270 Buy
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George Jan/Feb 2009 14-18 Buy
Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration Pereboom Marieke, Becker Matthijs L, Amenchar Mostapha, Verweij Sjoerd L, van der Hoeven Ruud TM, Mulder Inge J Jan/Feb 2015 70-72 Buy
Novel Approaches to Topical Psoriasis Therapy Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin Sep/Oct 2015 357-365 Buy
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J Jul/Aug 2004 313-319 Buy
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration Mody Vicky, Shah Samit, Patel Jaymin, Thomas Michael C May/Jun 2016 236-238 Buy